Abstract
Purpose. Secretory systems contribute to drug absorption in the gastrointestinal tract. The purpose of this study was the identification of members of the ATP binding cassette superfamily of secretory transport proteins that may potentially modulate drug absorption in Caco-2 cells, which are an important cellular model predicting enteral absorption of drugs.
Methods. Kinetic studies as well as PCR- and Western blot studies with confluent epithelial layers of human Caco-2 cells.
Results. The study demonstrates functional expression of multidrug resistance related protein (MRP) and P-glycoprotein (P-gp) in Caco-2 cells: 1) Efflux studies with the MRP specific substrate glutathion-methylfluorescein (GS-MF) showed functional activity of MRP in Caco-2 cells preloaded with the metabolic precursor of GS-MF, chloro-methylfluoresceine-diacetate, CMFDA. Excretion of GS-MF was decreased in presence of the MRP-blocker MK-571.2) Transport experiments with cyclosporin A demonstrated the functional activity of P-gp. Cellular accumulation was increased in presence of the P-gp blocking agent SDZ-PSC 833.3) The expression of the 190 kDa protein MRP and the 170 kDa protein P-gp in Caco-2 cells was shown by Western blot analysis with specific monoclonal antibodies. 4) The expression of MRP-mRNA in Caco-2 cells was detected by RT-PCR and compared with the MRP over-expressing cell line H69AR. MRP primers recognize specifically human MRP1 (GenBank accession number L05628), but not all other published sequences of MRP (MRP2-MRP6). P-gp expression on mRNA-level was also confirmed by RT-PCR.
Conclusions. The data demonstrate that besides P-gp, multidrug resistance related protein (MRP) is functionally expressed in Caco-2 cells and contributes to the active excretion of substrates in this cell line.
Similar content being viewed by others
REFERENCES
A. Lorico, G. Rappa, R. A. Finch, D. Yang, R. A. Flavell, and A. C. Sartorelli. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:5238-5242 (1997).
M. M. Gottesman and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427 (1993).
D. Keppler, I. Leier, and G. Jedlitschky. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378:787-791 (1997).
T. Fujita, H. Yamada, M. Fukuzumi, A. Nishimaki, A. Yamamoto, and S. Muranishi. Calcein is excreted from the intestinal mucosal cell membrane by the active transport system. Life Sci. 60:307-313 (1997).
A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:963-977 (1996).
G. Fricker, J. Drewe, J. Huwyler, H. Gutmann, and C. Beglinger. Relevance of P-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br. J. Pharmacol. 118:1841-1847 (1996).
A. Sparreboom, J. van-Asperen, U. Mayer, A. H. Schinkel, J. W. Smit, D. K. Meijer, P. Borst, W. J. Nooijen, J. H. Beijnen, and O. van Tellingen. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA. 94:2031-2035 (1997).
R. B. Kim, M. F. Fromm, C. Wandel, B. Leake, A. J. Wood, D. M. Roden, and G. R. Wilkinson. The drug transporter pglycoprotein limits oral absorption and brain entry of HIV-1 proteinase inhibitors. J. Clin. Invest. 101:289-294 (1998).
J. Alsenz, H. Steffen, and R. Alex. Active apical scretory efflux of the HIV-protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharm. Res. 15:423-428 (1998).
J. Karlsson, S. M. Kuo, J. Ziemniak, and P. Artursson. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Br. J. Pharmacol. 110:1009-1016 (1993).
H. Lennernas. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 49:627-638 (1997).
P. Anderle, E. Nederer, W. Rubas, C. Hilgendorf, H. Spahn-Langguth, H. Wunderli-Allenspach, H. P. Merkle, and P. Langguth. P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 87:757-762 (1998).
P. Artursson. Epithelial transport of drugs in cell culture. I.: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79:476-482 (1990).
A. R. Hilgers, R. A. Conradi, and P. S. Burton. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7:902-910 (1990).
H. Lennernäs. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 49:627-638 (1997).
T. Abe, T. Mori, S. Hori, K. Koike, and M. Kuwano. Multidrug resistance protein (MRP). Nippon Rinsho 55:1077-1082 (1997).
M. Kavallaris. The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance. Anticancer Drugs 8:17-25 (1997).
M. Müller and P. L. Jansen. Molecular aspects of hepatobiliary transport. Am. J. Physiol. 272:G1285-1303 (1997).
H. Roelofsen, T. A. Vos, I. J. Schippers, F. Kuipers, H. Koning, H. Moshage, P. L. Jansen, and M. Müller. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112:511-521 (1997).
S. E. Mirski and S. P. Cole. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line. Cancer Res. 49:5719-5724 (1989).
S. P. Cole, G. Bhardwaj, J. H. Gerlach, J. E. Mackie, C. E. Grant, K. C. Almquist, A. J. Stewart, E. U. Kurz, A. M. Duncan, and R. G. Deeley. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654 (1992).
M. J. Flens, G. J. Zaman, P. van der Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van der Groep, M. de Haas, C. J. Meijer, and R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1237-1247 (1996).
M. E. Cavet, M. West, and N. L. Simmons. Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 121:1567-1578 (1997).
P. F. Augustijns, T. P. Bradshaw, L. S. Gan, R. W. Hendren, and D. R. Thakker. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun. 197:360-365 (1993).
T. Terao, E. Hisanaga, Y. Sai, I. Tamai, and A. Tsuji: Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J. Pharm. Pharmacol. 48:1083-1089 (1996).
K. I. Hosoya, K. J. Kim, and V. H. Lee. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 13:885-890 (1996).
M. A. Barrand, A. C. Heppell-Parton, K. A. Wright, P. H. Rabbitts, and P. R. Twentyman. A 190-kilodalton protein overexpressed in non-p-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J. Natl.Cancer Inst. 86:110-117 (1994).
S. P. Cole, K. E. Sparks, K. Fraser, D. W. Loe, C. E. Grant, G. M. Wilson, and R. G. Deely. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902-5910 (1994).
G. Fricker and A. Fahr. Mechanisms of hepatic transport of cylosporin A—an explanation of its cholestatic action? Yale J. Biol. Med. 71:379-390 (1997).
T. Fujita, H. Yamada, M. Fukuzumi, A. Nishimaki, A. Yamamoto, and S. Muranishi. Calcein is excreted from the intestinal mucosal cell membrane by the active transport system. Life Sci. 60:307-13 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gutmann, H., Fricker, G., Török, M. et al. Evidence for Different ABC-Transporters in Caco-2 Cells Modulating Drug Uptake. Pharm Res 16, 402–407 (1999). https://doi.org/10.1023/A:1018825819249
Issue Date:
DOI: https://doi.org/10.1023/A:1018825819249